Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - epoetinum alfa - solution injectable (seringues) - epoetinum alfa 5000 u.i., polysorbatum 80, natrii chloridum, natrii dihydrogenophosphas dihydricus, dinatrii phosphas dihydricus, glycinum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium 1.544 mg. - la stimulation de l'Érythropoïèse - biotechnologika

Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - epoetinum alfa - solution injectable (seringues) - epoetinum alfa 6000 u.i., polysorbatum 80, natrii chloridum, natrii dihydrogenophosphas dihydricus, dinatrii phosphas dihydricus, glycinum, aqua ad iniectabile q.s. ad solutionem pro 0.6 ml corresp. natrium 1.853 mg. - la stimulation de l'Érythropoïèse - biotechnologika

Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - epoetinum alfa - solution injectable (seringues) - epoetinum alfa 8000 u.i., polysorbatum 80, natrii chloridum, natrii dihydrogenophosphas dihydricus, dinatrii phosphas dihydricus, glycinum, aqua ad iniectabile q.s. ad solutionem pro 0.8 ml corresp. natrium 2.466 mg. - la stimulation de l'Érythropoïèse - biotechnologika

Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - epoetinum alfa - solution injectable (seringues) - epoetinum alfa 30000 u.i., polysorbatum 80, natrii chloridum, natrii dihydrogenophosphas dihydricus, dinatrii phosphas dihydricus, glycinum, aqua ad iniectabile q.s. ad solutionem pro 0.75 ml corresp. natrium 3.699 mg. - la stimulation de l'Érythropoïèse - biotechnologika

Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

amgen switzerland ag - darbepoetinum alfa - solution injectable en seringue préremplie - darbepoetinum alfa 15 µg, natrii phosphates, natrii chloridum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 0.375 ml corresp., darbepoetinum alfa 40 µg/ml. - la stimulation de l'Érythropoïèse - biotechnologika

Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

amgen switzerland ag - darbepoetinum alfa - solution injectable en seringue préremplie - darbepoetinum alfa 130 mg, natrii phosphates ou, natrii chloridum, polysorbatum 80, eau pour iniectabilia q.s. la solution de 0,65 ml corresp., darbepoetinum alfa 200 µg/ml. - stimulierung der erythropoese - biotechnologika

Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

amgen switzerland ag - darbepoetinum alfa - solution injectable en vorgefülltem pen (sureclick) - darbepoetinum alfa 10 mg, natrii phosphates ou, natrii chloridum, polysorbatum 80, eau pour iniectabilia q.s. la solution de 0,4 ml corresp., darbepoetinum alfa 25 µg/ml. - stimulierung der erythropoese - biotechnologika

Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

amgen switzerland ag - darbepoetinum alfa - solution injectable en vorgefülltem pen (sureclick) - darbepoetinum alfa, 15 mg, natrii phosphates ou, natrii chloridum, polysorbatum 80, eau pour iniectabilia q.s. la solution pour le 0,375 ml corresp., darbepoetinum alfa 40 µg/ml. - stimulierung der erythropoese - biotechnologika

Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

amgen switzerland ag - darbepoetinum alfa - injektionslösung in vorgefülltem pen (sureclick) - darbepoetinum alfa 20 mg, natrii phosphates ou, natrii chloridum, polysorbatum 80, eau pour iniectabilia q.s. pour une solution au lieu de 0,5 ml, corresp., darbepoetinum alfa 40 µg/ml. - la stimulation de l'Érythropoïèse - biotechnologika

Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

amgen switzerland ag - darbepoetinum alfa - solution injectable en vorgefülltem pen (sureclick) - darbepoetinum alfa 30 mg, natrii phosphates ou, natrii chloridum, polysorbatum 80, eau pour iniectabilia q.s. la solution de 0,3 ml corresp., darbepoetinum alfa 100 µg/ml. - stimulierung der erythropoese - biotechnologika